Literature DB >> 20219245

Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma.

Mesut Seker, Bala Basak Oven Ustaalioğlu, Ahmet Bilici, Mahmut Emre Yildirim, Umut Kefeli, Nagehan Ozdemir Barisik, Ismet Tamer, Mahmut Gumus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20219245     DOI： 10.1016/j.leukres.2010.02.013

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  3 in total

1.  Pulmonary BALT lymphoma successfully treated with eight cycles weekly rituximab: report of first case and F-18 FDG PET/CT images.

Authors:  Ahmet Bilici; Mesut Seker; Bala Basak Oven Ustaalioglu; Nesrin Canpolat; Taflan Salepci; Mahmut Gumus
Journal:  J Korean Med Sci       Date:  2011-03-28       Impact factor: 2.153

2.  Long-term Therapeutic Success of Intravenous Rituximab in 26 Patients with Indolent Primary Cutaneous B-cell Lymphoma.

Authors:  Stefanie Porkert; Pamela Mai; Constanze Jonak; Felix Weihsengruber; Klemens Rappersberger; Wolfgang Bauer; Ingrid Simonitsch-Klupp; Markus Raderer; Julia Valencak
Journal:  Acta Derm Venereol       Date:  2021-02-02       Impact factor: 3.875

Review 3.  Cutaneous primary B-cell lymphomas: from diagnosis to treatment.

Authors:  Margarida Lima
Journal:  An Bras Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.896
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.